1. Transfusion-related acute lung injury after intravenous immunoglobulin treatment in a lung transplant recipient.
- Author
-
Stoclin A, Delbos F, Dauriat G, Brugière O, Boeri N, Métivier AC, Thabut G, Camus P, and Mal H
- Subjects
- Acute Lung Injury therapy, Graft Rejection etiology, Graft Rejection immunology, Graft Rejection therapy, Humans, Immunoglobulins, Intravenous administration & dosage, Male, Middle Aged, Acute Lung Injury etiology, Immunoglobulins, Intravenous adverse effects, Lung Transplantation adverse effects, Transfusion Reaction
- Abstract
Three weeks after single-lung transplantation for pulmonary fibrosis, a patient with high serum levels of de novo donor-specific antibodies received high-dose intravenous immunoglobulin (IVIG) infusion (scheduled dose: 2 g/kg on 2 days) to prevent antibody-mediated rejection. Within the first hours after completion of infusions, he experienced acute lung injury involving the transplanted lung. Given the clinical evolution and the absence of an alternative diagnosis, transfusion-related acute lung injury (TRALI) was diagnosed. The IVIG administered on each day was from the same batch. At day 110, because of an increase in the serum titers of donor-specific antibodies, IVIG therapy was reintroduced but from a different batch, with excellent clinical tolerance. The lung injury was explored biologically, but no mechanism was revealed. Given the increasing use of IVIG in solid-organ recipients, clinicians should be aware of possible TRALI after IVIG infusion., (© 2012 The Author(s). Vox Sanguinis © 2012 International Society of Blood Transfusion.)
- Published
- 2013
- Full Text
- View/download PDF